<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang ZZ</submitter><funding>NIH Oxford-Cambridge and Harvard Medical School Medical Scientist Training Program</funding><funding>Intramural Research Program of NIH, National Institute of Allergy and Infectious Diseases</funding><funding>Sanming Project of Medicine in Shenzhen</funding><pagination>e2009217118</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7958356</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>118(10)</volume><pubmed_abstract>Interleukin (IL)-37, an antiinflammatory IL-1 family cytokine, is a key suppressor of innate immunity. IL-37 signaling requires the heterodimeric IL-18R1 and IL-1R8 receptor, which is abundantly expressed in the gastrointestinal tract. Here we report a 4-mo-old male from a consanguineous family with a homozygous loss-of-function IL37 mutation. The patient presented with persistent diarrhea and was found to have infantile inflammatory bowel disease (I-IBD). Patient cells showed increased intracellular IL-37 expression and increased proinflammatory cytokine production. In cell lines, mutant IL-37 was not stably expressed or properly secreted and was thus unable to functionally suppress proinflammatory cytokine expression. Furthermore, induced pluripotent stem cell-derived macrophages from th</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>Homozygous IL37 mutation associated with infantile inflammatory bowel disease.</pubmed_title><pmcid>PMC7958356</pmcid><funding_grant_id>N/A</funding_grant_id><funding_grant_id>SZSM201812002</funding_grant_id><pubmed_authors>Gonzaga-Jauregui C</pubmed_authors><pubmed_authors>Ozen A</pubmed_authors><pubmed_authors>Zhang ZZ</pubmed_authors><pubmed_authors>Karakoc-Aydiner E</pubmed_authors><pubmed_authors>Baris S</pubmed_authors><pubmed_authors>Lenardo MJ</pubmed_authors><pubmed_authors>Sweeney CL</pubmed_authors><pubmed_authors>He T</pubmed_authors><pubmed_authors>Yao Y</pubmed_authors><pubmed_authors>Smith KGC</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Malech HL</pubmed_authors><pubmed_authors>Matthews HF</pubmed_authors><pubmed_authors>Ertem D</pubmed_authors><pubmed_authors>Su HC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Homozygous IL37 mutation associated with infantile inflammatory bowel disease.</name><description>Interleukin (IL)-37, an antiinflammatory IL-1 family cytokine, is a key suppressor of innate immunity. IL-37 signaling requires the heterodimeric IL-18R1 and IL-1R8 receptor, which is abundantly expressed in the gastrointestinal tract. Here we report a 4-mo-old male from a consanguineous family with a homozygous loss-of-function IL37 mutation. The patient presented with persistent diarrhea and was found to have infantile inflammatory bowel disease (I-IBD). Patient cells showed increased intracellular IL-37 expression and increased proinflammatory cytokine production. In cell lines, mutant IL-37 was not stably expressed or properly secreted and was thus unable to functionally suppress proinflammatory cytokine expression. Furthermore, induced pluripotent stem cell-derived macrophages from th</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2025-04-19T15:37:21.754Z</modification><creation>2025-04-19T15:37:21.754Z</creation></dates><accession>S-EPMC7958356</accession><cross_references><pubmed>33674380</pubmed><doi>10.1073/pnas.2009217118</doi></cross_references></HashMap>